AKAMON

This brand name is authorized in Cyprus, Hong Kong SAR China, Malta.

Active ingredients

The drug AKAMON contains one active pharmaceutical ingredient (API):

1	Bromazepam UNII X015L14V0O - BROMAZEPAM
	Bromazepam is a pyridylbenzodiazepine compound with anxiolytic properties.
	Read more about Bromazepam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AKAMON Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BA08	Bromazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	25345, 25346
MT	Medicines Authority	MA032/00101, MA032/00102